Charles Q. Morris
2013
In 2013, Charles Q. Morris earned a total compensation of $2.6M as Executive Vice President and Chief Development Officer at ImmunoGen.
Compensation breakdown
| Bonus | $250,000 |
|---|---|
| Non-Equity Incentive Plan | $108,129 |
| Option Awards | $1,350,922 |
| Salary | $252,639 |
| Stock Awards | $596,500 |
| Other | $1,891 |
| Total | $2,560,081 |
Morris received $1.4M in option awards, accounting for 53% of the total pay in 2013.
Morris also received $250K in bonus, $108.1K in non-equity incentive plan, $252.6K in salary, $596.5K in stock awards and $1.9K in other compensation.
Rankings
In 2013, Charles Q. Morris' compensation ranked 3,050th out of 12,286 executives tracked by ExecPay. In other words, Morris earned more than 75.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,050 out of 12,286 | 75th |
Division Manufacturing | 1,024 out of 4,612 | 78th |
Major group Chemicals And Allied Products | 268 out of 1,462 | 82nd |
Industry group Drugs | 182 out of 1,156 | 84th |
Industry Pharmaceutical Preparations | 151 out of 890 | 83rd |
Source: SEC filing on September 29, 2015.
Morris' colleagues
We found four more compensation records of executives who worked with Charles Q. Morris at ImmunoGen in 2013.